ネバダ州における転移性癌の臨床試験
ネバダ州内の拠点で、転移性癌に関する10件の研究が参加者を募集しています。
ネバダ州内の都市
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- OptumCare Cancer Care at Charleston, Las Vegas
- Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas
- Summerlin Hospital Medical Center, Las Vegas
- 他2件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
- Comprehensive Cancer Centers, Las Vegas
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT07562152Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Renown Health Medical Oncology, Reno
- Renown Regional Medical Center, Reno
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- Renown Health Medical Oncology, Reno
- Renown Office of Clinical Research, Reno
- Renown Regional Medical Center, Reno
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Comprehensive Cancer Centers of Nevada, Las Vegas
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07218380A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- The Center of Hope, Reno
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer
- Research Site, Reno
被験者募集中第3相
18歳〜130歳 · 全性別 · 2026/09/08更新 · NCT07647328A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Comprehensive Cancer Centers of Nevada, Las Vegas
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
- Comprehensive Cancer Centers of Nevada, Las Vegas
被験者募集中第1相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07029399A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
- Comprehensive Cancer Center of Nevada, Las Vegas
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/15更新 · NCT06657144ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。